Bay1816032 CAS No.:1891087-61-8

Introduction

As a leading manufacturer in China, we are proud to offer our latest and greatest product – Bay1816032 CAS No.:1891087-61-8 – to merchants worldwide. As a trusted supplier in the marketplace, we understand the importance of providing high-quality, reliable products that exceed our client's expectations.

Bay1816032 is a powerful and effective chemical compound widely used in the pharmaceutical industry. It has the potential for immunomodulation and anti-inflammatory effects, and it is considered a promising candidate for novel drug development in a broad range of therapeutic areas. If you are looking for a premium product for your business, Bay1816032 is the perfect choice.

Chemical Properties

Bay1816032 has a molecular formula of C27H32N2O2S and a molecular weight of 460.63. It is a white crystalline powder with a melting point of approximately 128-133°C. Its solubility in water is moderate, and Bay1816032 is stable under normal conditions. When properly stored, it has a long shelf life, making it a reliable choice for pharmaceutical companies worldwide.

Applications

Our Bay1816032 chemical compound has a broad range of applications in the pharmaceutical industry. As a selective cytokine release inhibitor, Bay1816032 has potential applications in several therapeutic areas, including:

1. Multiple sclerosis

2. Dermatology

3. Cancer

4. Gastroenterology

5. Rheumatology

It has the potential to interfere with the production and release of pro-inflammatory cytokines, leading to a marked reduction of inflammation. If you are in the business of manufacturing products in the above therapeutic areas, Bay1816032 is an essential ingredient to incorporate into your products.

Quality Guarantee

At our manufacturing plant, we take great pride in the quality of our products. Our state-of-the-art facility is equipped with advanced technology allowing us to manufacture high-quality products that meet rigorous industry standards. We use only the highest quality raw materials, and our production process is subject to rigorous quality control procedures. This ensures that every batch of Bay1816032 CAS No.:1891087-61-8 that we produce is of exceptional quality.

Packaging and Delivery

We understand that delivery time is crucial in today's fast-paced business world. Therefore, we work tirelessly to ensure that our products reach clients promptly. Our Bay1816032 is packaged in air-tight containers to ensure its quality during transportation. Additionally, to expedite delivery, we deliver products using proven logistic techniques and ensure products reach their destination in a timely manner, allowing you to speed up production without delay.

Conclusion

In conclusion, our Bay1816032 CAS No.:1891087-61-8 chemical compound is a quality product manufactured with precision and care. We are committed to providing our clients with a reliable, high-quality product that meets and exceeds their expectations. Our range of applications in the pharmaceutical industry is extensive, making this product a valuable commodity for your business. If you are looking for a premium product that meets global standards, consider Bay1816032 as a valuable addition to your product line.

Chemical Structure : BAY-1816032

CAS No.: 1891087-61-8

 

BAY-1816032(BAY1816032, BAY 1816032)

Catalog No.: URK-V693  Only Used For Lab.

BAY1816032 (BAY1816032) is a highly potent, selective, orally active BUB1 mitotic checkpoint serine/threonine kinase with IC50 of 7 nM, displays excellent selectivity on a panel of 395.

Biological Activity

BAY1816032 (BAY1816032) is a highly potent, selective, orally active BUB1 mitotic checkpoint serine/threonine kinase with IC50 of 7 nM, displays excellent selectivity on a panel of 395 kinases; abrogates nocodazole-induced Thr-120 phosphorylation of the major BUB1 target protein histone H2A in HeLa cells with IC50 of 29 nM, induces lagging chromosomes and mitotic delay, inhibits proliferation of various tumor cell lines with mean IC50 of 1.4 uM; demonstrates synergy or additivity with paclitaxel or docetaxel both in vitro and in vivo.

Physicochemical Properties

References

1. Gerhard Siemeister, et al. Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity. AACR. DOI: 10.1158/1538-7445.

2. Siemeister G, et al. Clin Cancer Res. 2018 Nov 14. pii: clincanres.0628.2018.

URK-V693_COA

URK-V693_SDS

URK-V693_TDS

 

Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!

Why choose us?

• Our company is a Chinese factory that specializes in high-quality Cell Cycle/DNA Damage products.
• We are constantly improving our technology to respond more quickly to customer needs for the Bay1816032 CAS No.:1891087-61-8.
• Our products are backed by a comprehensive warranty to ensure customer satisfaction.
• Our company always adhere to the concept of people-oriented, to serve customers with scientific and technological innovation.
• Our company is registered and certified to ensure compliance with industry standards.
• Relying on our own technical advantages and management advantages, we strive to create Bay1816032 CAS No.:1891087-61-8 that is superior to the current level in the market in terms of product performance and quality.
• We offer a wide range of Cell Cycle/DNA Damage products to suit your specific needs.
• Our company will enhance customer satisfaction through high quality with international competitiveness, and excellent service.
• Our supply chain is carefully managed to ensure on-time delivery of our products.
• We analyzed the core competitiveness of our Bay1816032 CAS No.:1891087-61-8, the advantages and disadvantages of our products in marketing conditions, the opportunities and challenges in the external market, and constantly improve ourselves.

Hot Tags: bay1816032 cas no.:1891087-61-8, China bay1816032 cas no.:1891087-61-8, inhibitors for sepsis research, inhibitors for pathogen recognition, inhibitors for cancer research, epigenetic library for epigenetic analysis of epigenetic genotype, epigenetic library for epigenetic dysregulation, inhibitors for drug resistance